AISLING CAPITAL PARTNERS LLC
Insider CIK 1376171 · ADMA 10% owner · ESPR 10% owner · CEMP 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-24 | 2015-04-27 | 5,743 | $108.00 | $620.2K | 1,898,851 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-24 | 2015-04-27 | 61,726 | $106.10 | $6.55M | 1,837,125 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-23 | 2015-04-27 | 150,000 | $109.10 | $16.36M | 1,904,594 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | P Buy | 2013-10-22 | 2013-10-23 | 411,765 | $8.50 | $3.50M | 3,620,143 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 497,666 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 71,237 | — | $0 | 71,237 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 238,119 | $14.00 | $3.33M | 2,054,594 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 1,816,475 | SEC↗ |
| CEMP CEMPRA, INC. | P Buy | 2012-02-07 | 2012-02-09 | 1,213,663 | $6.00 | $7.28M | 3,293,060 | SEC↗ |